IRVING, Texas, April 16, 2024 /PRNewswire/ — Xstim, Inc., a pioneering developer and manufacturer of cutting-edge bone growth stimulation systems, is thrilled to announce its recent Premarket Application (PMA) approval from the U.S. Food and Drug Administration (FDA) for Xstim™ Spine Fusion Stimulator

Patent portfolio with over 100 patents, issued and pending, protects technology targeting a $100 billion market opportunity

The 3D printed PEEK implants using the EXT 220 MED were successfully demonstrated in nearly 40 cranioplasties across Europe in recent months says the company.

FastWave Medical announced today that it received a fourth utility patent to strengthen the IP foundation of its IVL platform.